A new study conducted at the Stanford University School of Medicine in Palo Alto, California indicates that the addition of drugs to standard chemotherapy treatments has not proven successful for patients afflicted with osteosarcoma. According to lead author Dr. Neyssa Marina, the study, conducted on more than 600 osteosarcoma patients in 17 countries shows that "adding two drugs to standard chemotherapy not only failed to improve patients' outcomes, it also increased toxic side effects." This finding has led Dr. Marina and colleagues to search for new treatment methods, namely targeting cancer-causing gene mutations.
To read more about this study, click here.
No comments:
Post a Comment